Physician

Alan Jeremy Gandler, M.D.

According to 2025 Medicare claims, Alan Gandler, M.D. (NPI: 1336535913) practices pulmonary disease in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN - MEDICAL GROUP (NPI: 1003923707; TIN: 232743545) and primary practice location at 19107-6130.

Gandler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 242 traditional Medicare patients, billed 646 HCPCS/CPT codes, and received $54,441 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,592 prescription claims across 218 beneficiaries totaling $547,540 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 371 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $995 to $547,540. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	104	287	$30,047
2022	260	847	$67,703
2023	266	747	$64,404
2024	242	646	$54,441

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	15	34	$995
2016	27	60	$6,273
2017	48	149	$7,208
2018	35	91	$7,435
2019	16	58	$16,188
2020	24	142	$28,366
2021	82	268	$63,250
2022	180	1,296	$399,068
2023	210	1,516	$580,590
2024	218	1,592	$547,540

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	194	$53,395
2023	14	304	$60,979
2024	14	371	$58,446

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	45	112	$171
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	37	39	$140
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	101	155	$73
94729	Test to examine how well the lungs exchange gases	36	40	$6
94010	Test to measure expiratory airflow and volume	39	43	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	197	6,810	$142,363
Fasenra Pen	Benralizumab	19	980	$106,858
Dupixent Pen	Dupilumab	22	588	$68,762
Breo Ellipta	Fluticasone/Vilanterol	81	2,580	$33,291
Spiriva Respimat	Tiotropium Bromide	45	1,470	$24,817

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	44	$44,349
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	14	117	$8,150
E1392	Portable oxygen concentrator, rental	Y	N/R	59	$1,967
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	19	$1,431
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	N/R	15	$1,304

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Alan Jeremy Gandler, M.D.?

Tedicare shows public-source Medicare data for Alan Jeremy Gandler, M.D. (NPI 1336535913), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Jeremy Gandler, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan Jeremy Gandler, M.D.?

Alan Jeremy Gandler, M.D. is linked to UNIVERSITY OF PENN - MEDICAL GROUP (billing NPI 1003923707) in the available physician profile data.

Does Alan Jeremy Gandler, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.